GT Biopharma, Inc.·4

Mar 19, 2:38 PM ET

Urbanski Raymond W. 4

4 · GT Biopharma, Inc. · Filed Mar 19, 2019

Insider Transaction Report

Form 4
Period: 2019-02-01
Urbanski Raymond W.
Chief Medical Officer
Transactions
  • Sale

    common stock

    2019-02-01$0.00/sh176,980$1771,351,918 total
Footnotes (1)
  • [F1]The disposal of the 176,980 shares was made to satisfy obligations pursuant to the terms of a Stock Pledge Agreement signed on August 1, 2018.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT